Adiponectin Testing Market Analysis

Type (ELISA, Enzyme Immunoassay)

The global adiponectin testing market is segmented and analyzed for demand and supply by type into ELISA, enzyme immunoassay, and others, out of which, the ELISA segment is anticipated to hold the largest share in the global adiponectin testing market during the forecast period on account of its higher utilization in the monitoring of therapeutic drug level. Moreover, the significant utilization of ELISA in the examination of the antibodies in the blood is projected to propel the growth of the market over the forecast period. ELISA adiponectin test is done to determine the presence of antibodies in the patient’s body. These antibodies are produced by the patient t fight against harmful antigens such as viruses. ELISA applications are also included in the HIV, rotavirus, syphilis, Lyme disease, and pernicious anemia. The normal values for the adiponectin ELISA test were found to be around 4-26 mcg/ml which has to be the same in both male and female patients at all age groups. A specific enzyme is mixed with the sample of blood to obtain a colored result in the presence of any antigen. The rising number of people with cardiac problems and obesity is estimated to boost the market growth. According to the Centers for Disease Control and Prevention in 2020 around 697,000 people died suffering from heart disease in the United States.

End-user (Hospitals, Diagnostic Laboratories, Specialty Clinics)

The global adiponectin testing market is also segmented and analyzed for demand and supply by end-user in hospitals, diagnostic laboratories, and specialty clinics.  Amongst these three segments, the hospitals segment is expected to garner a significant share. The hospitals are where people prefer to visit in the first place, especially during serious conditions such as heart disease or heart pain. The availability of multispecialty doctors and the presence of advanced equipment is a plus for hospitals which increases the market segment growth in the coming years. The growing demand for hospitals is also attributed to the growing number of cases of heart disorders, overweight, and cholesterol issues. The increasing number of people suffering from cholesterol and blockage of blood vessels is increasing with the increasing economic standards of people. It is reported that over 90 million population in the U.S. were suffering from cholesterol levels higher than 200mg/dL in the year 2022.

Our in-depth analysis of the global market includes the following segments: